- Home
- VABK vs ABEO Comparison
VABK vs ABEO Comparison
Compare VABK & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VABK
- ABEO
- Stock Information
- Founded
- VABK 1998
- ABEO 1974
- Country
- VABK United States
- ABEO United States
- Employees
- VABK N/A
- ABEO N/A
- Industry
- VABK Major Banks
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- VABK Finance
- ABEO Health Care
- Exchange
- VABK Nasdaq
- ABEO Nasdaq
- Market Cap
- VABK 206.0M
- ABEO 260.1M
- IPO Year
- VABK N/A
- ABEO 1980
- Fundamental
- Price
- VABK $36.74
- ABEO $5.49
- Analyst Decision
- VABK
- ABEO Strong Buy
- Analyst Count
- VABK 0
- ABEO 5
- Target Price
- VABK N/A
- ABEO $18.00
- AVG Volume (30 Days)
- VABK 5.0K
- ABEO 3.0M
- Earning Date
- VABK 04-24-2025
- ABEO 05-19-2025
- Dividend Yield
- VABK 3.84%
- ABEO N/A
- EPS Growth
- VABK 3.77
- ABEO N/A
- EPS
- VABK 3.30
- ABEO N/A
- Revenue
- VABK $55,119,000.00
- ABEO N/A
- Revenue This Year
- VABK N/A
- ABEO N/A
- Revenue Next Year
- VABK N/A
- ABEO $539.93
- P/E Ratio
- VABK $11.15
- ABEO N/A
- Revenue Growth
- VABK 1.78
- ABEO N/A
- 52 Week Low
- VABK $28.71
- ABEO $3.93
- 52 Week High
- VABK $44.00
- ABEO $7.32
- Technical
- Relative Strength Index (RSI)
- VABK 55.53
- ABEO 50.66
- Support Level
- VABK $35.91
- ABEO $4.87
- Resistance Level
- VABK $37.51
- ABEO $7.08
- Average True Range (ATR)
- VABK 0.84
- ABEO 0.58
- MACD
- VABK 0.19
- ABEO 0.01
- Stochastic Oscillator
- VABK 73.47
- ABEO 31.20
About VABK Virginia National Bankshares Corporation
Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses and charitable organizations.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.